Investment and innovation - for a modern health care

Carasent is an investment management company with a special focus on businesses that develop entrepreneurial and e-health solutions. 

We believe in innovation that offers a new kind of accessibility and availability for patients and practises, and offer intellectual and financial capital for participants that wishes to provide high quality services.

In the spring of 2018 Apptix ASA, now Carasent, acquired Evimeria EMR AB, a swedish company that deliver web based solutions and electronic medical records (EMRs). An important goal with the investment was to create new possibilities for our businesses. 

Our strategies and assets makes it possible for the companies to grow and establish new and increased market presence. 

Carasent ASA has acquired the Swedish company Medrave Software AB, including its fully-owned Norwegian subsidiary Medrave Software AS (together “Medrave”), a market leader in Scandinavia within quality improvement software for healthcare practices within primary care and secondary outpatient care.

– We are very pleased to have completed this transaction with Medrave. Its complementary products will strengthen Carasent’s offering and provide cross sale potential within primary and specialist care in Sweden. Medrave is also aiming to scale up their presence in the Norwegian market, which is well in line with our own strategy of launching Webdoc in Norway, says Dennis Höjer, CEO of Carasent

Medrave was established in Sweden in 2007 by the two doctors Per Stenström and Svein Gjelstad, however, history dates back to 1997 when Per Stenström led an internal project in Region Stockholm to develop a reporting tool for quality improvement to primary care clinics. Medrave’s modulebased software provides clinical reports to GPs, physiotherapists, child care, urgent care, youth care, mental health and habilative care practices.

The quality improvement solution automatically collects and sorts data, analyze and visualize, tracks and benchmarks KPIs, and provides automatic reporting. As such, healthcare professionals save time, get better overview, can reach goals easier, and have consistent and improved reporting – ensuring safer care for all patients.

– We are impressed by the module-based software solutions that the Medrave team has developed over many years and look forward to work with 16 new highly competent and motivated employees. The quality improvements tools developed by Medrave will expand our offering with a product in high demand among our customer base and enable us to service our clients in a new segment, the public healthcare sector. In summary, this transaction provides a strong rationale adding a new product to our portfolio in line with communicated strategic priorities of expanding within product, segment and geographical dimensions, Höjer adds. 

Medrave has an attractive customer base of more than 260 clients across Sweden and Norway, covering 1,646 practices and an estimated 8.8 million patients, with ~60% of revenue from the public sector in 2020.

In relation to the acqusition, Carasent will host a webcast to present the acquisition 16 December at 08:00 CET. The presentation will be given by Dennis Höjer, CEO and Svein Martin Bjørnstad, CFO. Please use the following link to access the presentation:

See full press release here!


Evimeria and Mindler have entered a cooperation agreement that entails the parties to collaborate in the development of a platform under the working name Webdoc X. The platform being developed is a scalable platform aimed to support Mindler in their expansion in Europe.

– Webdoc X is tailored to meet a large European market with big needs of digitization and cost-effective solutions, says Evimeria’s CEO Dennis Höjer, noting that the agreement aligns with the company’s own ambitions outside Sweden and the Nordic region:
– The cooperation with Mindler is of high importance to us and we find great value in the fact that we are two Swedish companies that together are making a major investment in expansion further into Europe.

Webdoc X is based on the same principle as the Webdoc medical record system, which is currently being used by more than 500 clinics in Sweden. Like its origin platform, Webdoc X is a cloud-based SAAS service, but tailored to meet the needs of the international market. The platform is based on the idea of scalability and that the healthcare provider can adapt the platform themselves by mixing and adding modules as needs arise or change.

For Mindler as a digital healthcare provider with presence in several countries, including the Netherlands and France today, and several more planned for the near future, the agreement grants the opportunity to meet differential conditions and markets within one platform, and confirms Webdoc X as a scalable solution:

– We are happy to work with Evimeria for our continued expansion and making the best mental health care in the world. The Webdoc X platform makes it possible for us to continue to scale our digital healthcare solution for our patients and psychologists, says Magnus Pettersson, Head of International Expansion, Mindler.

About the companies:

Evimeria EMR AB
Evimeria is a software company that develops, sells and delivers e-health services to caregivers in the Nordic region. The business is based on the vision of patient focused care with minimized administration. The core products are the medical record system Webdoc, and Vårdrummet – a digital platform for communication between caregivers and patients. Evimeria currently has 60 employees and is a wholly owned subsidiary of Carasent ASA, which is listed on the Oslo Børs.

Mindler AB
The digital psychology provider Mindler was founded in 2018. Today the tech company has 300 accredited psychologists that are associated with the app and that together offer care in over 20 different languages. Mindler’s head office is located in Stockholm, but the company is expanding and is currently meeting the demand for psychologist services in both Sweden and Europe.

Contact, Evimeria EMR AB:
Name: Dennis Höjer, CEO.
Phone: +46 733 28 49 22
Mail: [email protected]

Contact, Mindler AB:
Name: Amalie Angelskår, CMO
Mail: [email protected]

See full press release here!


The Company is pleased to announce that it has allocated 11,007,031 new shares
in the Private Placement at a subscription price of NOK 33.40 per share, raising
gross proceeds of NOK 368 million. DNB Markets, a part of DNB Bank ASA acted as
Sole Manager (the “Manager”) in connection with the Private Placement.

The Company intends to use the net proceeds from the Private Placement to
finance the acquisition of Metodika AB, as announced on 25 May 2021, finance
future potential acquisitions and strengthen the ability to capitalize on
organic growth opportunities, as well as for general corporate purposes.

The share capital increase pertaining to the Private Placement was resolved by
the Board of Directors of the Company (the “Board”) on 25 May 2021 pursuant to
an authorization granted by the Company’s general meeting held 14 January 2021
(the “Authorization”). Notification of allotment of the Offer Shares including
settlement instructions will be sent to the applicants through a notification
from the Manager on 26 May 2021.

See full press release here!


Carasent ASA has acquired the Swedish company Metodika AB (“Metodika”), a leading provider of Enterprise Practice Management (EPM) solutions to independent hospitals and clinics across 10 European countries.

– We are very pleased to have completed this transaction as Metodika, with its complementary market presence will expand Carasent’s geographical footprint significantly by giving access to new European markets such as Denmark, Finland, UK, Germany and Italy, says Dennis Höjer, CEO of Carasent.

Metodika EPM software streamlines information management and efficiently helps its clients with handling the day-to-day operations of clinics and hospitals. The product platform also includes a tool for inpatient care that is complementary to Carasent’s current offering.

– We are impressed by the EPM solution that the Metodika team has developed and look forward to work with its robust organization of 22 highly competent employees. The tool for treatment and surgery will expand our product offering and enable us to service our clients in a new sub-segment. In summary, this transaction is well in-line with communicated strategic priorities of expanding within geographical, segment and product dimensions, he says.

Metodika has an attractive customer base of more than 50 clients across Europe. The company also has growing SaaS-business that can be further intensified under Carasent ownership.

See full press release here!


Want to know more? Download the latest financial reports and other notifications in the section below

Smart and sustainable development

We believe in healthy development. Many, but small steps forward, to reach new levels of growth and expansion. Every company have different needs when it comes to investments and goals, and therefore we make sure to map out your specifik pre-conditions before we launch a new project or campain. 

Interested in our work? Do you have any questions on how we would undertake your business? 

Contact us now!